Fingerprint
Dive into the research topics of 'SWOG S0722: Phase II study of mTOR inhibitor everolimus (RAD001) in advanced Malignant Pleural Mesothelioma (MPM)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
SWOG S0722: Phase II study of mTOR inhibitor everolimus (RAD001) in advanced Malignant Pleural Mesothelioma (MPM)
Sai Hong Ignatius Ou, James Moon, Linda L. Garland, Philip C. Mack, Joseph R. Testa, Anne S. Tsao, Antoniette J. Wozniak, David R. Gandara
Research output: Contribution to journal › Article › peer-review
65
Scopus
citations